Skip to main content
. 2025 Apr;66(4):612–619. doi: 10.2967/jnumed.124.268700

FIGURE 1.

FIGURE 1.

Schema of study A26. aProportion of scans with τAD+ (∼5%) and τAD++ (∼95%) reflected prevalence in TB2 study. bScans that were negative or had failed FTP quantitation were not used for calculating endpoints. cParticipants with negative scans were identified from screen-failed subjects to TB2 study.